JAMA Oncology

Published by: American Medical Association  

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Cercek Hanjis
    Cercek Hanjis
  4. Crane
    Crane
  5. Abou-Alfa
    Abou-Alfa
  6. Gonen
    Gonen
  7. Paty
    Paty
  8. Varghese
    Varghese
  9. Yaeger
    Yaeger
  10. Diaz
    Diaz

Groups

  1. Department of Medicine (33)
  2. Gastrointestinal Oncology Service (33)
  3. Solid Tumor Oncology Division (33)
  4. Center for Pancreatic Cancer Research (19)
  5. Epidemiology and Biostatistics (6)
  6. Surgery (6)
  7. Survivorship Research (6)
  8. Biostatistics Service (5)
  9. Radiation Oncology, Department of (5)
  10. Colorectal Surgery (4)
Search Within
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (25)
  2. Correspondence (4)
  3. Editorial (2)
  4. Miscellaneous (1)
  5. Review (1)
Groups
  1. Department of Medicine (33)
  2. Gastrointestinal Oncology Service (33)
  3. Solid Tumor Oncology Division (33)
  4. Center for Pancreatic Cancer Research (19)
  5. Epidemiology and Biostatistics (6)
  6. Surgery (6)

More Groups

People
  1. Leonard Saltz (10)
  2. Eileen O'Reilly (8)
  3. Andrea Cercek Hanjis (6)
  4. Anna Varghese (5)
  5. Christopher Crane (5)
  6. Ghassan Abou-Alfa (4)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (3)
  5. 2020 (8)
  6. 2019 (4)

More Years

Publishers
  1. American Medical Association (33)

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HIMALAYA overall survival prominence and other routes to the peak
    Correspondence

    Abou-Alfa, G. K.; Sangro, B.
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: The phase 2b NIFTY randomized clinical trial
    Journal Article

    Hyung, J.; Kim, I.; Kim, K. P.; Ryoo, B. Y.; Jeong, J. H.; Kang, M. J.; Cheon, J.; Kang, B. W.; Ryu, H.; Lee, J. S.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Association of inflammatory biomarkers with survival among patients with stage III colon cancer
    Journal Article

    Cheng, E.; Shi, Q.; Shields, A. F.; Nixon, A. B.; Shergill, A. P.; Ma, C.; Guthrie, K. A.; Couture, F.; Kuebler, P.; Kumar, P.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX plus radiotherapy in patients with borderline resectable pancreatic cancer-The A021501 Trial - In reply
    Correspondence

    Katz, M. H. G.; Herman, J. M.; O'Reilly, E. M.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Subacute abdominal pain in a patient with chronic liver disease and hepatocellular carcinoma
    Miscellaneous

    Zheng-Lin, B.; Faleck, D. M.; Harding, J. J.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial
    Journal Article

    Katz, M. H. G.; Shi, Q.; Meyers, J.; Herman, J. M.; Chuong, M.; Wolpin, B. M.; Ahmad, S.; Marsh, R.; Schwartz, L.; Behr, S.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Association of antineoplastic therapy with decreased SARS-CoV-2 infection rates in patients with cancer
    Journal Article

    Foote, M. B.; White, J. R.; Jee, J.; ArgileĢs, G.; Wan, J. C. M.; Rousseau, B.; Pessin, M. S.; Diaz, L. A. Jr
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: The phase 3 randomized clinical ClarIDHy trial
    Journal Article

    Zhu, A. X.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V. T.; Borad, M. J.; Bridgewater, J. A.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer
    Journal Article

    Reyngold, M.; O'Reilly, E. M.; Varghese, A. M.; Fiasconaro, M.; Zinovoy, M.; Romesser, P. B.; Wu, A.; Hajj, C.; Cuaron, J. J.; Tuli, R.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Weight-based dosing of pembrolizumab every 6 weeks in the time of COVID-19
    Editorial

    Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.
    JAMA Oncology (2020)

    Fulltext@MSK | Save

    • JAMA Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JAMA Oncology 2374-2437 American Medical Association
    JAMA oncology 23742445 Unknown
    Jama Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 23742437 Unknown
    JAMA Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 2374-2437 American Medical Association
    JAMA Oncology 2374-2445 American Medical Association
    JAMA Oncology 23742437 American Medical Association